MDXH Stock Analysis: Buy, Sell, or Hold?
MDXH - MDxHealth SA Ordinary Shares
$0.48
0.01 (1.11%)
▲
5d:
-15.44%
30d:
-39.87%
90d:
-83.39%
WAIT
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When MDXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MDXH is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MDXH is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDXH is currently trading at $0.47, which is considered oversold relative to its 30-day fair value range of $0.54 to $0.82.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is currently testing key support at $0.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MDXH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.90 (+517.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDXH is in a strong downtrend. The price is currently testing key support at $0.51. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MDXH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.90 (+517.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.54 -
$0.82
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 517.3% below Wall St target ($2.90)
- WARNING: Recommendation downgraded due to -15.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.54 -
$0.82
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.51
Resistance Level
$0.79
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.24
Wall Street Target
$2.90
(+517.3%)
Revenue Growth (YoY)
12.7%
Profit Margin
-29.9%
Share & Embed Analysis
Last updated: June 25, 2026 10:16 AM ET
Data refreshes hourly during market hours. Next update: 11:16 AM
Data refreshes hourly during market hours. Next update: 11:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 62 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 66 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 65 BUY |
